Statistical Approaches to Establishing Bioequivalence
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 2, 2022
January 11, 2023
ecbc1c62-e39f-4980-b654-baa7788c2171
Related Documents
Establishing Impurity Specifications for Antibiotics
Guidance DocumentApril 20, 2026Center for Drug Evaluation and Research
Pulmonary Tuberculosis: Developing Drugs for Treatment
Guidance DocumentDecember 14, 2022Center for Drug Evaluation and Research
Data Integrity for In Vivo Bioavailability and Bioequivalence Studies
Guidance DocumentApril 3, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox